DIFFUSE MIDLINE GLIOMA
Clinical trials for DIFFUSE MIDLINE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE MIDLINE GLIOMA trials appear
Sign up with your email to follow new studies for DIFFUSE MIDLINE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets deadly childhood brain cancers
Disease control Not yet recruitingThis study tests a combination of a vaccine (PEP-CMV) and an immunotherapy drug (nivolumab) in children and young adults with certain aggressive brain tumors. The goal is to see if this approach is safe and helps the immune system fight the cancer. About 68 participants will be e…
Matched conditions: DIFFUSE MIDLINE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for kids with tough brain cancers: experimental drug trial launches
Disease control Not yet recruitingThis early-phase study tests an experimental drug called gallium maltolate in 15 children whose high-grade glioma or atypical teratoid rhabdoid tumor has returned or not responded to standard treatment. The main goals are to find a safe dose and understand side effects. All parti…
Matched conditions: DIFFUSE MIDLINE GLIOMA
Phase: PHASE1 • Sponsor: Sarah Rumler • Aim: Disease control
Last updated May 04, 2026 16:22 UTC